Cargando…

In Silico Analysis of SARS-CoV-2 Spike Proteins of Different Field Variants

Coronaviruses belong to the group of RNA family of viruses that trigger diseases in birds, humans, and mammals, which can cause respiratory tract infections. The COVID-19 pandemic has badly affected every part of the world. Our study aimed to explore the genome of SARS-CoV-2, followed by in silico a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haseeb, Muhammad, Amir, Afreenish, Ikram, Aamer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145761/ https://www.ncbi.nlm.nih.gov/pubmed/37112648 http://dx.doi.org/10.3390/vaccines11040736

Ejemplares similares

Probing SARS-CoV-2 sequence diversity of Pakistani isolates
por: Rehman, Zaira, et al.
Publicado: (2021)

Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion
por: Jimenez Ruiz, Jose A., et al.
Publicado: (2022)

An in-silico study of the mutation-associated effects on the spike protein of SARS-CoV-2, Omicron variant
por: Shishir, Tushar Ahmed, et al.
Publicado: (2022)

In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein
por: Lin, Yu-Chao, et al.
Publicado: (2022)

In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern
por: Rajpoot, Sajjan, et al.
Publicado: (2021)

In Silico Comparative Analysis of the Functional, Structural, and Evolutionary Properties of SARS-CoV-2 Variant Spike Proteins
por: Math, Renukaradhya K, et al.
Publicado: (2022)

Combatting future variants of SARS-CoV-2 using an in-silico peptide vaccine approach by targeting the spike protein
por: Biswas, Subhamoy, et al.
Publicado: (2022)

Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study
por: Nag, Anish, et al.
Publicado: (2022)

In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
por: Maffucci, Irene, et al.
Publicado: (2020)

In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
por: Ling, Rongsong, et al.
Publicado: (2020)

In silico design of quadruplex aptamers against the spike protein of SARS-CoV-2
por: Behbahani, Mandana, et al.
Publicado: (2021)

Binder design for targeting SARS-CoV-2 spike protein: An in silico perspective
por: Etemadi, Ali, et al.
Publicado: (2022)

SARS-CoV-2 variants – Evolution, spike protein, and vaccines
por: Chen, Kai-Wei K., et al.
Publicado: (2022)

The Spike of Concern—The Novel Variants of SARS-CoV-2
por: Winger, Anna, et al.
Publicado: (2021)

SARS-CoV-2 spike variants differ in their allosteric responses to linoleic acid
por: Oliveira, A Sofia F, et al.
Publicado: (2023)

In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds
por: Babaeekhou, Laleh, et al.
Publicado: (2021)

Proliferation of SARS-CoV-2 B.1.1.7 Variant in Pakistan-A Short Surveillance Account
por: Umair, Massab, et al.
Publicado: (2021)

Breakthrough cases of Omicron and Delta variants of SARS-CoV-2 during the fifth wave in Pakistan
por: Jamal, Zunera, et al.
Publicado: (2022)

Footprints of SARS-CoV-2 genome diversity in Pakistan, 2020–2021
por: Rehman, Zaira, et al.
Publicado: (2022)

The SARS-CoV-2 spike protein is vulnerable to moderate electric fields
por: Arbeitman, Claudia R., et al.
Publicado: (2021)

Evolving spike-protein N-glycosylation in SARS-CoV-2 variants
por: Baboo, Sabyasachi, et al.
Publicado: (2023)

Therapeutic Potential of Novel Mastoparan-Chitosan Nanoconstructs Against Clinical MDR Acinetobacter baumannii: In silico, in vitro and in vivo Studies
por: Hassan, Afreenish, et al.
Publicado: (2021)

Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis
por: Ortega, Joseph Thomas, et al.
Publicado: (2021)

SARS CoV-2 spike protein variants exploit DC-SIGN/DC-SIGNR receptor for evolution and severity: an in-silico insight
por: Gupta, Jyoti, et al.
Publicado: (2023)

SARS-CoV-2 spike therapeutic antibodies in the age of variants
por: Baum, Alina, et al.
Publicado: (2021)

SARS-CoV-2 variants, spike mutations and immune escape
por: Harvey, William T., et al.
Publicado: (2021)

Conformational stability of SARS-CoV-2 glycoprotein spike variants
por: Arruda, Hiam R.S., et al.
Publicado: (2022)

Distinct neutralizing kinetics and magnitudes elicited by different SARS-CoV-2 variant spikes
por: Liu, Yang, et al.
Publicado: (2021)

In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis
por: Harisna, Azza Hanif, et al.
Publicado: (2021)

Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis
por: Rodal Canales, Francisco Javier, et al.
Publicado: (2021)

Temporal-Geographical Dispersion of SARS-CoV-2 Spike Glycoprotein Variant Lineages and Their Functional Prediction Using in Silico Approach
por: Boon, Siaw Shi, et al.
Publicado: (2021)

In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2
por: Jain, Anisha S., et al.
Publicado: (2021)

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
por: Weisblum, Yiska, et al.
Publicado: (2020)

Structural dynamics of prefusion spike protein of SARS-CoV-2 and its variants
por: Derakhshani-Molayousefi, Mortaza, et al.
Publicado: (2022)

Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants
por: Mittal, Anshumali, et al.
Publicado: (2022)

Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein
por: Xu, Shiqi, et al.
Publicado: (2022)

Progressive membrane-binding mechanism of SARS-CoV-2 variant spike proteins
por: Overduin, Michael, et al.
Publicado: (2022)

Differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concern
por: Tyrkalska, Sylwia D., et al.
Publicado: (2022)

Characterization and Function of Glycans on the Spike Proteins of SARS-CoV-2 Variants of Concern
por: Zheng, Luping, et al.
Publicado: (2022)

Quantitative profiling of N-glycosylation of SARS-CoV-2 spike protein variants
por: Xie, Yongjing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gqm93o56dbc16pchd161n6nl00